COMMONWEALTH EQUITY SERVICES, LLC - IDERA PHARMACEUTICALS INC ownership

IDERA PHARMACEUTICALS INC's ticker is IDRA and the CUSIP is 45168K405. A total of 48 filers reported holding IDERA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.78 and the average weighting 0.0%.

Quarter-by-quarter ownership
COMMONWEALTH EQUITY SERVICES, LLC ownership history of IDERA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$30
-99.9%
87,412
+1.0%
0.00%
Q3 2022$32,000
-17.9%
86,537
-0.1%
0.00%
Q2 2022$39,000
-9.3%
86,6620.0%0.00%
Q1 2022$43,000
-12.2%
86,6620.0%0.00%
Q4 2021$49,000
-44.9%
86,6620.0%0.00%
Q3 2021$89,000
-13.6%
86,6620.0%0.00%
Q2 2021$103,000
+114.6%
86,662
+130.9%
0.00%
Q1 2021$48,000
-50.5%
37,537
+40.8%
0.00%
Q4 2020$97,000
+120.5%
26,662
+27.5%
0.00%
Q3 2020$44,000
+18.9%
20,912
-0.0%
0.00%
Q2 2020$37,000
+37.0%
20,9150.0%0.00%
Q1 2020$27,000
-28.9%
20,915
-0.1%
0.00%
Q4 2019$38,000
-36.7%
20,9400.0%0.00%
Q3 2019$60,000
+9.1%
20,9400.0%0.00%
Q2 2019$55,000
+14.6%
20,940
+9.3%
0.00%
Q1 2019$48,000
-9.4%
19,1500.0%0.00%
Q4 2018$53,000
-68.8%
19,1500.0%0.00%
-100.0%
Q3 2018$170,00019,1500.00%
Other shareholders
IDERA PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
ABG Innovation Capital Partners III GP Ltd 56,250$206,0000.12%
Baker Brothers Advisors 4,608,786$16,914,0000.06%
Artal Group S.A. 500,000$1,835,0000.04%
HOLLENCREST CAPITAL MANAGEMENT 90,000$331,0000.04%
Spotlight Asset Group, Inc. 21,500$79,0000.03%
DCF Advisers, LLC 18,755$69,0000.03%
683 Capital Management, LLC 88,470$325,0000.02%
Palo Alto Investors LP 77,044$283,0000.02%
Alpine Global Management, LLC 13,966$51,0000.01%
TCI Wealth Advisors, Inc. 4,000$15,0000.01%
View complete list of IDERA PHARMACEUTICALS INC shareholders